StartUps
"Our job is to help students realize their ideas towards the establishment of a successful company.”
Hi, what are you looking for?
"Our job is to help students realize their ideas towards the establishment of a successful company.”
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
On the occasion of the Israel Museum’s 50th anniversary, a new exhibition space in the Shrine of the Book is inaugurated with this...
Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA), the world’s fifth largest generic pharmaceutical company and India’s top pharmaceutical company, and the Technion, Israel’s institute...
Shares of Teva Pharmaceutical Industries traded up 0.87% on Monday, hitting $62.52.
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
“Eyelid motion provides us with meaningful information about the health status of a patient.”